Neurocrine Biosciences Inc - Company Profile
Powered by 
All the sales intelligence you need on Neurocrine Biosciences Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Neurocrine Biosciences Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Neurocrine Biosciences Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Neurocrine Biosciences Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Neurocrine Biosciences Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
William H. Rastetter, Ph.D.
Chairman Executive BoardMr. William H. Rastetter has been the Chairman of the company since 2011. Prior to this, he served as the Executive Chairman of Biogen Idec Inc. Previously, he served as the Chief Executive Officer of IDEC Pharmaceuticals Corporation. Currently, he also serves as the Chairman of the Board of Directors for Fate Therapeutics.
Kyle W. Gano
Director; Chief Executive Officer Executive BoardMr. Kyle W. Gano has been the Chief Executive Officer, President, and Director of the company since October 2024. Prior to this, he served as the Chief Business Development and Strategy Officer of the company from 2011 to 2024. Currently, he also serves as the Board of Director at Pharmaceutical Research and Manufacturers of America (PhRMA).
Matthew C. Abernethy
Chief Financial Officer Senior ManagementMr. Matthew C. Abernethy has been the Chief Financial Officer of the company since 2017. Prior to this, he served as the Vice President, Investor Relations and Treasurer and Vice President of Finance for the Americas and Global Product Engines at Zimmer Biomet. Mr. Abernethy also served as the Certified Public Accountant at KPMG LLP.
Lewis Choi
Chief Information Officer Senior ManagementMr. Lewis Choi has been the Chief Information Officer of the company since June 2025.
Darin M. Lippoldt
Secretary; Chief Legal Officer Senior ManagementMr. Darin M. Lippoldt has been the Chief Legal Officer and Secretary of the company since 2014. Prior to this, he served as the Executive Vice President, Chief Compliance Officer, Corporate Secretary and General Counsel of Volcano Corporation. Mr. Lippoldt also served as the Associate General Counsel at Amylin Pharmaceuticals, Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer